<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Biomed Middle East &#187; Biomed Company News</title>
	<atom:link href="http://biomedme.com/news/biomed-company-news/feed" rel="self" type="application/rss+xml" />
	<link>http://biomedme.com</link>
	<description>Medical Equipments for Middle East</description>
	<lastBuildDate>Thu, 09 Sep 2010 13:31:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
		<item>
		<title>GE Healthcare&#8217;s flutemetamol phase 2 study results published in &#8216;Annals of Neurology&#8217;</title>
		<link>http://biomedme.com/health-care/ge-healthcares-flutemetamol-phase-2-study-results-published-in-annals-of-neurology_11573.html</link>
		<comments>http://biomedme.com/health-care/ge-healthcares-flutemetamol-phase-2-study-results-published-in-annals-of-neurology_11573.html#comments</comments>
		<pubDate>Thu, 09 Sep 2010 04:39:52 +0000</pubDate>
		<dc:creator>imran</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=11573</guid>
		<description><![CDATA[GE Healthcare announced today that results from its multicenter phase 2 study of flutemetamol were published in the September issue of Annals of Neurology. Flutemetamol is an investigational positron emission tomography (PET) imaging agent being developed by GE Healthcare, in the field of brain imaging. The purpose of the phase 2 study was to investigate [...]]]></description>
		<wfw:commentRss>http://biomedme.com/health-care/ge-healthcares-flutemetamol-phase-2-study-results-published-in-annals-of-neurology_11573.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GE Donates Web-based EMR To University Of Texas Program</title>
		<link>http://biomedme.com/biomed-company-news/ge-donates-web-based-emr-to-university-of-texas-program_10483.html</link>
		<comments>http://biomedme.com/biomed-company-news/ge-donates-web-based-emr-to-university-of-texas-program_10483.html#comments</comments>
		<pubDate>Fri, 27 Aug 2010 13:53:18 +0000</pubDate>
		<dc:creator>imran</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Healthcare IT]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=10483</guid>
		<description><![CDATA[GE Healthcare is bringing today&#8217;s EMR technology to tomorrow&#8217;s practitioners by donating its latest platform to the University of Texas at Austin for educational use. The University&#8217;s Health Information Technology Summer Certificate Program just graduated its first class of 54 students at the end of July. These students used GE Centricity® Advance software in the [...]]]></description>
		<wfw:commentRss>http://biomedme.com/biomed-company-news/ge-donates-web-based-emr-to-university-of-texas-program_10483.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Johnson &amp; Johnson gets FDA warning over marketing</title>
		<link>http://biomedme.com/biomed-company-news/johnson-johnson-gets-fda-warning-over-marketing_10413.html</link>
		<comments>http://biomedme.com/biomed-company-news/johnson-johnson-gets-fda-warning-over-marketing_10413.html#comments</comments>
		<pubDate>Fri, 27 Aug 2010 01:02:13 +0000</pubDate>
		<dc:creator>imran</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=10413</guid>
		<description><![CDATA[The FDA notified Johnson &#038; Johnson&#8217;s DePuy Orthopaedics Inc. that it is selling one product that was never approved for sale and is selling another product for uses that have not been specifically approved. In a letter to the company, the FDA wrote that DePuy is marketing its Corail Hip System for two unapproved uses, [...]]]></description>
		<wfw:commentRss>http://biomedme.com/biomed-company-news/johnson-johnson-gets-fda-warning-over-marketing_10413.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Siemens Introduces New Solutions For The Diagnosis And Therapy Of Heart Diseases</title>
		<link>http://biomedme.com/health-care/siemens-introduces-new-solutions-for-the-diagnosis-and-therapy-of-heart-diseases_10401.html</link>
		<comments>http://biomedme.com/health-care/siemens-introduces-new-solutions-for-the-diagnosis-and-therapy-of-heart-diseases_10401.html#comments</comments>
		<pubDate>Thu, 26 Aug 2010 14:09:34 +0000</pubDate>
		<dc:creator>imran</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>
		<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=10401</guid>
		<description><![CDATA[At the Congress of the European Society of Cardiology (ESC) 2010, Siemens Healthcare presents the company&#8217;s innovative solutions for cardiology that provide higher quality of care and contribute at the same time to reducing costs in healthcare. The objective is to diagnose heart diseases more effectively as well as earlier but also to enable new [...]]]></description>
		<wfw:commentRss>http://biomedme.com/health-care/siemens-introduces-new-solutions-for-the-diagnosis-and-therapy-of-heart-diseases_10401.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Saladax Biomedical &amp; Bristol-Myers Squibb together to Develop Clinical Diagnostics</title>
		<link>http://biomedme.com/biomed-company-news/saladax-biomedical-bristol-myers-squibb-together-to-develop-clinical-diagnostics_8585.html</link>
		<comments>http://biomedme.com/biomed-company-news/saladax-biomedical-bristol-myers-squibb-together-to-develop-clinical-diagnostics_8585.html#comments</comments>
		<pubDate>Wed, 23 Jun 2010 08:05:31 +0000</pubDate>
		<dc:creator>jamal</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=8585</guid>
		<description><![CDATA[BETHLEHEM, Pa., Jun 21, 2010 Saladax Biomedical, Inc. announced today that it has entered into a multi-year development and commercialization agreement with Bristol-Myers Squibb for the development of certain clinical diagnostic tests to be used in conjunction with the development of certain therapeutic compounds in the Bristol-Myers Squibb pipeline. &#8220;This collaboration demonstrates our capability to [...]]]></description>
		<wfw:commentRss>http://biomedme.com/biomed-company-news/saladax-biomedical-bristol-myers-squibb-together-to-develop-clinical-diagnostics_8585.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dutch Regulators blame GE for Failing to Report Omniscan NSF Case</title>
		<link>http://biomedme.com/biomed-company-news/dutch-regulators-blame-ge-for-failing-to-report-omniscan-nsf-case_8578.html</link>
		<comments>http://biomedme.com/biomed-company-news/dutch-regulators-blame-ge-for-failing-to-report-omniscan-nsf-case_8578.html#comments</comments>
		<pubDate>Mon, 21 Jun 2010 11:39:45 +0000</pubDate>
		<dc:creator>jamal</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=8578</guid>
		<description><![CDATA[The Danish Medicines Agency has charged that GE Healthcare violated Dutch law when it failed to promptly and completely inform regulators about a patient who died after developing nephrogenic systemic fibrosis (NSF) following exposure to Omniscan contrast dye. According to a report on ProPublica’s Web site, because the statute of limitations had expired, the agency [...]]]></description>
		<wfw:commentRss>http://biomedme.com/biomed-company-news/dutch-regulators-blame-ge-for-failing-to-report-omniscan-nsf-case_8578.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dubai Healthcare City seeks to make Dubai a global health care destination</title>
		<link>http://biomedme.com/uae/dubai-healthcare-city-seeks-to-make-dubai-a-global-health-care-destination_8570.html</link>
		<comments>http://biomedme.com/uae/dubai-healthcare-city-seeks-to-make-dubai-a-global-health-care-destination_8570.html#comments</comments>
		<pubDate>Thu, 17 Jun 2010 22:36:06 +0000</pubDate>
		<dc:creator>jamal</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>
		<category><![CDATA[Medical Tourism]]></category>
		<category><![CDATA[Regional News]]></category>
		<category><![CDATA[United Arab Emirates]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=8570</guid>
		<description><![CDATA[Dubai Healthcare City (DHCC) is under new management. DHCC parent Dubai Holding has had problems and has restructured. Tatweer, who used to manage DHCC, has been replaced by Tecom Investments.Tatweer failed to promote DHCC in the last 18 months, but Tecom seeks to be pro-active again. DHCC is a free zone in Dubai with a [...]]]></description>
		<wfw:commentRss>http://biomedme.com/uae/dubai-healthcare-city-seeks-to-make-dubai-a-global-health-care-destination_8570.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Siemens launches new software for prenatal risk analysis</title>
		<link>http://biomedme.com/biomed-company-news/siemens-launches-new-software-for-prenatal-risk-analysis_8568.html</link>
		<comments>http://biomedme.com/biomed-company-news/siemens-launches-new-software-for-prenatal-risk-analysis_8568.html#comments</comments>
		<pubDate>Thu, 17 Jun 2010 22:10:16 +0000</pubDate>
		<dc:creator>jamal</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>
		<category><![CDATA[Healthcare IT]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=8568</guid>
		<description><![CDATA[Siemens has launched a new software package, which works in conjunction with its medical device range to help clinicians assess prenatal risks. The new PRISCA version 5.0 prenatal risk calculation software is designed to combine data collected from Immulite maternal screening assays and ultrasound measurements, which can be used to assess risks of foetal chromosomal [...]]]></description>
		<wfw:commentRss>http://biomedme.com/biomed-company-news/siemens-launches-new-software-for-prenatal-risk-analysis_8568.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GE offers e-health records as SaaS offering</title>
		<link>http://biomedme.com/biomed-company-news/ge-offers-e-health-records-as-saas-offering_8566.html</link>
		<comments>http://biomedme.com/biomed-company-news/ge-offers-e-health-records-as-saas-offering_8566.html#comments</comments>
		<pubDate>Wed, 16 Jun 2010 14:21:51 +0000</pubDate>
		<dc:creator>jamal</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>
		<category><![CDATA[Healthcare IT]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=8566</guid>
		<description><![CDATA[GE&#8217;s Healthcare division today announced its first electronic medical record (EMR) product in a software-as-a-service (SaaS) platform aimed at small or remote physician practices with a lower-cost, monthly fee model. GE Healthcare&#8217;s Centricity Advance product offers a combination of EMR, physician administrative management and patient portals. GE said the SaaS offering differs from a traditional [...]]]></description>
		<wfw:commentRss>http://biomedme.com/biomed-company-news/ge-offers-e-health-records-as-saas-offering_8566.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>InfuSystem Acquires First Biomedical, Inc. USA</title>
		<link>http://biomedme.com/biomed-company-news/infusystem-acquires-first-biomedical-inc-usa_8563.html</link>
		<comments>http://biomedme.com/biomed-company-news/infusystem-acquires-first-biomedical-inc-usa_8563.html#comments</comments>
		<pubDate>Wed, 16 Jun 2010 14:11:16 +0000</pubDate>
		<dc:creator>jamal</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=8563</guid>
		<description><![CDATA[MADISON HEIGHTS, MI, USA Jun 15, 2010 InfuSystem Holdings, Inc., leading supplier of infusion services to oncologists and other outpatient treatment settings, announced today that it has acquired First Biomedical, Inc. for total consideration of $17.2 million. First Biomedical sells, rents, services and repairs new and pre-owned infusion pumps and other medical equipment. The company [...]]]></description>
		<wfw:commentRss>http://biomedme.com/biomed-company-news/infusystem-acquires-first-biomedical-inc-usa_8563.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medline Expands Surgical Suite Product Portfolio With Proxy Biomedical Surgical</title>
		<link>http://biomedme.com/hospital-news/medline-expands-surgical-suite-product-portfolio-with-proxy-biomedical-surgical_8548.html</link>
		<comments>http://biomedme.com/hospital-news/medline-expands-surgical-suite-product-portfolio-with-proxy-biomedical-surgical_8548.html#comments</comments>
		<pubDate>Sun, 13 Jun 2010 11:05:45 +0000</pubDate>
		<dc:creator>jamal</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>
		<category><![CDATA[Hospital News]]></category>
		<category><![CDATA[Infection Control]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=8548</guid>
		<description><![CDATA[Medline Industries, Inc., the nation&#8217;s largest privately held manufacturer and distributor of healthcare supplies, announced today the signing of an exclusive agreement with Proxy Biomedical Limited to distribute its surgical mesh biomaterials for the repair and reinforcement of tissue. The agreement includes MotifMESH® and VitaMESH® products for the repair and reinforcement of hernia and other [...]]]></description>
		<wfw:commentRss>http://biomedme.com/hospital-news/medline-expands-surgical-suite-product-portfolio-with-proxy-biomedical-surgical_8548.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Philips Healthcare investing $33M in Cleveland R&amp;D center</title>
		<link>http://biomedme.com/biomed-company-news/philips-healthcare-investing-33m-in-cleveland-rd-center_8523.html</link>
		<comments>http://biomedme.com/biomed-company-news/philips-healthcare-investing-33m-in-cleveland-rd-center_8523.html#comments</comments>
		<pubDate>Fri, 04 Jun 2010 17:06:22 +0000</pubDate>
		<dc:creator>jamal</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=8523</guid>
		<description><![CDATA[Philips Healthcare is investing more than $33 million in the first phase of a medical imaging research and development center at University Hospitals Case Medical Center in Cleveland. The investment by the Dutch imaging technology company — which could double if a second phase follows — was announced at an afternoon press conference along with [...]]]></description>
		<wfw:commentRss>http://biomedme.com/biomed-company-news/philips-healthcare-investing-33m-in-cleveland-rd-center_8523.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Siemens Healthcare adds to its MoodLight portfolio with new MRI systems</title>
		<link>http://biomedme.com/biomed-company-news/siemens-healthcare-adds-to-its-moodlight-portfolio-with-new-mri-systems_8494.html</link>
		<comments>http://biomedme.com/biomed-company-news/siemens-healthcare-adds-to-its-moodlight-portfolio-with-new-mri-systems_8494.html#comments</comments>
		<pubDate>Sat, 29 May 2010 14:26:06 +0000</pubDate>
		<dc:creator>jamal</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=8494</guid>
		<description><![CDATA[Siemens Healthcare recently expanded its range of MoodLight products with the introduction of its latest MRI systems, the Magnetom Aera and Magnetom Skyra. The LED MoodLights have been introduced as a means of improving the patient experience during what can be an anxiety-provoking examination. The two MRIs join the Mammomat Inspiration Full Field Digital Mammography [...]]]></description>
		<wfw:commentRss>http://biomedme.com/biomed-company-news/siemens-healthcare-adds-to-its-moodlight-portfolio-with-new-mri-systems_8494.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Boston Scientific Teams With Philips, Siemens</title>
		<link>http://biomedme.com/biomed-company-news/boston-scientific-teams-with-philips-siemens_8492.html</link>
		<comments>http://biomedme.com/biomed-company-news/boston-scientific-teams-with-philips-siemens_8492.html#comments</comments>
		<pubDate>Sat, 29 May 2010 14:21:02 +0000</pubDate>
		<dc:creator>jamal</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=8492</guid>
		<description><![CDATA[Boston Scientific, the Natick-based medical device manufacturer, announced it has teamed with Philips Healthcare and Siemens Medical Solutions to provide doctors with a tool that can give a 360-degree view of the heart. Boston Scientific&#8217;s iLab ultrasound imaging system will work with the Philips Allura Xper and the Siemens AXIOM x-ray systems to create an [...]]]></description>
		<wfw:commentRss>http://biomedme.com/biomed-company-news/boston-scientific-teams-with-philips-siemens_8492.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>J&amp;J Criticized Over Drug Recall</title>
		<link>http://biomedme.com/general/jj-criticized-over-drug-recall_8488.html</link>
		<comments>http://biomedme.com/general/jj-criticized-over-drug-recall_8488.html#comments</comments>
		<pubDate>Sat, 29 May 2010 14:10:10 +0000</pubDate>
		<dc:creator>jamal</dc:creator>
				<category><![CDATA[Biomed Company News]]></category>
		<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://biomedme.com/?p=8488</guid>
		<description><![CDATA[FRIDAY, May 28 Criminal penalties could be levied against the Johnson &#38; Johnson division responsible for a recent massive recall of pediatric medications, a U.S. Food and Drug Administration official said Thursday. The FDA is &#8220;considering additional enforcement actions against the company for its pattern of noncompliance, which may include seizures, injunction or criminal penalties,&#8221; [...]]]></description>
		<wfw:commentRss>http://biomedme.com/general/jj-criticized-over-drug-recall_8488.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
